Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness and Safety of JAK Inhibitors in Autoinflammatory Diseases: A Systematic Review
Zhivana Boyadzhieva, Nikolas Ruffer, Gerd R Burmester, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies
Zhivana Boyadzhieva, Nikolas Ruffer, Ina Kötter, et al.
Lara D. Veeken (2023) Vol. 62, Iss. 11, pp. 3518-3525
Closed Access | Times Cited: 55
Relapsing polychondritis: clinical updates and new differential diagnoses
Philippe Mertz, N. Costedoat‐Chalumeau, Marcela A. Ferrada, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 6, pp. 347-360
Closed Access | Times Cited: 10
Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options
Sara Bindoli, Chiara Baggio, Andrea Doria, et al.
Drugs (2024) Vol. 84, Iss. 3, pp. 257-274
Open Access | Times Cited: 7
Efficacy and safety of therapies for Still’s disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still’s disease
Sara Bindoli, Arianna De Matteis, Stéphane Mitrovic, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225854
Closed Access | Times Cited: 7
Revealing innovative JAK1 and JAK3 inhibitors: a comprehensive study utilizing QSAR, 3D-Pharmacophore screening, molecular docking, molecular dynamics, and MM/GBSA analyses
Abdelmoujoud Faris, Ivana Cacciatore, Radwan Alnajjar, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 6
JAK inhibitors in rheumatology
Kunihiro Yamaoka, Kenji Oku
Immunological Medicine (2023) Vol. 46, Iss. 3, pp. 143-152
Open Access | Times Cited: 12
Long-Term Safety Profile and Off-Label Use of JAK Inhibitors in Dermatological Disorders
L. Corbella‐Bagot, Constanza Riquelme‐Mc Loughlin, D. Morgado-Carrasco
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 9, pp. 784-801
Open Access | Times Cited: 11
Toward a personalized therapy of Still’s disease based on immunologic endotypes: a narrative review
Po‐Ku Chen, Shiow-Jiuan Wey, Der‐Yuan Chen
Expert Review of Clinical Immunology (2025)
Closed Access
Emerging treatment approaches for VEXAS syndrome: a systematic review and meta-analysis
Berkay Kılıç, Efe Sacin, Muhammet Kadir Tanin, et al.
Annals of Hematology (2025)
Open Access
Neutrophilic Urticarial Dermatosis: A Window into Systemic Inflammation and Autoimmune Disorders
Xiaoxuan Cai, Yadan Zheng, Changyi Yang, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
The Future of JAK Inhibitors in Dermatology
İlayda Uysal, İlteriş Oğuz Topal
(2025), pp. 153-159
Closed Access
Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs
Piero Ruscitti, Dennis McGonagle, V. Garcìa, et al.
The Journal of Rheumatology (2024) Vol. 51, Iss. 5, pp. 442-451
Open Access | Times Cited: 3
JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study
Marie Solignac, Natalia Cabrera, Marine Fouillet-Desjonquères, et al.
Journal of Autoimmunity (2024) Vol. 147, pp. 103248-103248
Open Access | Times Cited: 3
VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic): clinical review in a rapidly emerging field
Luan Phan, Danielle Hammond, Nathaniel R. Wilson, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 9, pp. 1245-1257
Closed Access | Times Cited: 2
Computational insights into rational design and virtual screening of pyrazolopyrimidine derivatives targeting Janus kinase 3 (JAK3)
Abdelmoujoud Faris, Ivana Cacciatore, Radwan Alnajjar, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 2
Type 1 diabetes and inborn errors of immunity: Complete strangers or 2 sides of the same coin?
Gaia Mancuso, Camillo Bechi Genzano, Alessandra Fierabracci, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 6, pp. 1429-1447
Closed Access | Times Cited: 6
Renal involvement in monogenic autoinflammatory diseases: A narrative review
Saverio La Bella, Armando Di Ludovico, Giulia Di Donato, et al.
Nephrology (2023) Vol. 28, Iss. 7, pp. 363-371
Open Access | Times Cited: 5
Update on autoinflammatory diseases
Kosar Asna Ashari, Jonathan S. Hausmann, Fatma Dedeoğlu
Current Opinion in Rheumatology (2023) Vol. 35, Iss. 5, pp. 285-292
Closed Access | Times Cited: 4
[Artículo traducido] Perfil de seguridad a largo plazo y usos fuera de indicación de los inhibidores de JAK en dermatología
L. Corbella‐Bagot, Constanza Riquelme‐Mc Loughlin, D. Morgado-Carrasco
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 9, pp. T784-T801
Open Access | Times Cited: 4
JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use
Philippe Guilpain
Lara D. Veeken (2022) Vol. 62, Iss. 4, pp. 1368-1369
Open Access | Times Cited: 7
Exploring the potential of Toxoplasma gondii in drug development and as a delivery system
Chanjin Yoon, Yu Seong Ham, Woo Jin Gil, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 2, pp. 289-300
Open Access | Times Cited: 1
Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review
Jasper F. Nies, Udo Schneider, Martin Krusche
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 6
What General Neurologists Should Know about Autoinflammatory Syndromes?
Marianna Pinheiro Moraes de Moraes, Renan Rodrigues Neves Ribeiro do Nascimento, Fabiano Ferreira Abrantes, et al.
(2023)
Open Access | Times Cited: 3
<i>JAK2</i>, <i>STAT3</i> Gene Polymorphisms in Turkish Patients with Behçet’s Disease
Darya Farhoomand Aksoy, Rahime Aksoy, Sevim Gönen, et al.
Gazi Medical Journal (2024) Vol. 35, Iss. 1, pp. 64-68
Open Access
STING‐associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions
I. Latour‐Álvarez, Laura Murcia‐Clemente, I. Vázquez Pigueiras, et al.
Pediatric Dermatology (2024) Vol. 41, Iss. 5, pp. 893-896
Closed Access
Page 1 - Next Page

Scroll to top